Susquehanna International Group
NUVB icon

Susquehanna International Group’s Nuvation Bio NUVB Stock Holding History

Susquehanna International Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$616K Buy
143,613
+127,751
+805% +$712K ﹤0.01% 9119
2025
Q4 		$142K Sell
15,862
-802,917
-98% -$4.97M ﹤0.01% 11218
2025
Q3 		$3.03M Buy
818,779
+423,240
+107% +$1.15M ﹤0.01% 4957
2025
Q2 		$771K Buy
395,539
+146,458
+59% +$305K ﹤0.01% 8110
2025
Q1 		$438K Buy
249,081
+168,419
+209% +$383K ﹤0.01% 9185
2024
Q4 		$215K Buy
80,662
+66,177
+457% +$170K ﹤0.01% 10580
2024
Q3 		$33.2K Sell
14,485
-5,814
-29% -$17.7K ﹤0.01% 11511
2024
Q2 		$59.3K Buy
+20,299
New +$61.9K ﹤0.01% 11335
2024
Q1 		– Sell
-154,083
Closed -$233K – 12967
2023
Q4 		$233K Buy
154,083
+139,861
+983% +$180K ﹤0.01% 10365
2023
Q3 		$19.1K Sell
14,222
-31,881
-69% -$53.1K ﹤0.01% 11616
2023
Q2 		$83K Sell
46,103
-72,456
-61% -$123K ﹤0.01% 11083
2023
Q1 		$197K Buy
118,559
+93,186
+367% +$189K ﹤0.01% 10614
2022
Q4 		$48.7K Sell
25,373
-50,298
-66% -$102K ﹤0.01% 11412
2022
Q3 		$170K Buy
+75,671
New +$216K ﹤0.01% 11075
2022
Q2 		– Sell
-11,827
Closed -$62K – 13607
2022
Q1 		$62K Sell
11,827
-48,358
-80% -$272K ﹤0.01% 12210
2021
Q4 		$512K Buy
60,185
+37,566
+166% +$345K ﹤0.01% 9138
2021
Q3 		$225K Sell
22,619
-49,806
-69% -$451K ﹤0.01% 11224
2021
Q2 		$674K Buy
72,425
+39,287
+119% +$448K ﹤0.01% 8838
2021
Q1 		$346K Buy
+33,138
New +$371K ﹤0.01% 10316

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's NUVB Position: Q1 2026 in Review

Susquehanna International Group increased its Nuvation Bio (NUVB) stake by 805% in Q1 2026, buying an estimated $712K and bringing the position to 143,613 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #9119.

Susquehanna International Group first reported a position in NUVB in Q1 2021 and has held it in 19 quarters since. The position peaked at $3.03M in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Susquehanna International Group held 143,613 shares of Nuvation Bio worth $616K as of Q1 2026.
  • Susquehanna International Group bought 127,751 Nuvation Bio shares in Q1 2026, an estimated $712K.
  • Nuvation Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9119 holding.
  • Susquehanna International Group first reported a position in Nuvation Bio in Q1 2021 and has held it in 19 quarters since.
  • Susquehanna International Group's Nuvation Bio position peaked at $3.03M in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.